SSA
PTLA

Schonfeld Strategic Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Schonfeld Strategic Advisors’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-13,114
Closed -$94K – 1662
2020
Q1 		$94K Buy
13,114
+2,903
+28% +$36.2K 0.01% 1009
2019
Q4 		$244K Sell
10,211
-116,754
-92% -$3.22M 0.01% 1073
2019
Q3 		$3.4M Buy
126,965
+25,365
+25% +$712K 0.1% 218
2019
Q2 		$2.76M Sell
101,600
-141,690
-58% -$4.44M 0.1% 237
2019
Q1 		$8.44M Buy
243,290
+133,890
+122% +$3.86M 0.29% 90
2018
Q4 		$2.13M Buy
109,400
+51,700
+90% +$1.06M 0.08% 308
2018
Q3 		$1.54M Buy
57,700
+32,600
+130% +$1.06M 0.07% 340
2018
Q2 		$948K Buy
+25,100
New +$960K 0.05% 403
2018
Q1 		– Sell
-9,279
Closed -$451K – 1054
2017
Q4 		$451K Buy
+9,279
New +$469K 0.04% 486
2017
Q3 		– Sell
-20,990
Closed -$1.18M – 846
2017
Q2 		$1.18M Buy
+20,990
New +$841K 0.12% 241
2016
Q3 		– Sell
-12,043
Closed -$285K – 601
2016
Q2 		$285K Buy
+12,043
New +$297K 0.06% 322

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Schonfeld Strategic Advisors's PTLA Position: Q2 2020 in Review

Schonfeld Strategic Advisors sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 13,114 shares — an estimated $94K sold.

Schonfeld Strategic Advisors first reported a position in PTLA in Q2 2016 and held it in 11 quarters. The position peaked at $8.44M in Q1 2019. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • Schonfeld Strategic Advisors reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 13,114 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $94K.
  • Schonfeld Strategic Advisors first reported a position in Portola Pharmaceuticals, Inc. in Q2 2016 and held it in 11 quarters.
  • Schonfeld Strategic Advisors's Portola Pharmaceuticals, Inc. position peaked at $8.44M in Q1 2019.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.